-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Tp5y/TsRHFmcIRW4wJbIIq9iFKsP8VaCuibsC8swjK+mhmi5+jnn2UYQLZwExGzQ XteP2FKGBCZRGhA5/znoJA== 0001179110-03-003074.txt : 20030703 0001179110-03-003074.hdr.sgml : 20030703 20030702205838 ACCESSION NUMBER: 0001179110-03-003074 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030701 FILED AS OF DATE: 20030703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CROUCH TAYLOR CENTRAL INDEX KEY: 0001197086 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30833 FILM NUMBER: 03773565 MAIL ADDRESS: STREET 1: 9640 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRUKER DALTONICS INC CENTRAL INDEX KEY: 0001109354 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043110160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 44 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 MAIL ADDRESS: STREET 1: 44 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 4 1 edgar.xml FORM 4 - X0101 4 2003-07-01 0 0001109354 BRUKER DALTONICS INC BRKR 0001197086 CROUCH TAYLOR 1 0 0 0 Stock Option (right to buy) 7.14 2003-07-01 4 A 0 12600 7.14 A 2001-11-10 2010-11-10 Common Stock 12600 12600 D Stock Option (right to buy) 11.11 2003-07-01 4 A 0 1575 11.11 A 2002-11-01 2011-11-01 Common Stock 1575 1575 D Stock Option (right to buy) 3.65 2003-07-01 4 A 0 1575 3.65 A 2003-11-10 2012-11-10 Common Stock 1575 1575 D In connection with the merger of Bruker AXS Inc. into Bruker Daltonics Inc., now known as Bruker BioSciences Corporation (the "Merger"), filer's option to receive 20,000 shares of Bruker AXS Inc. common stock was converted into an option to receive 12,600 shares of Bruker BioSciences Corporation common stock with the same vesting schedule at a purchase price of $7.14 per share. In connection with the Merger, filer's option to receive 2,500 shares of Bruker AXS Inc. common stock was converted into an option to receive 1,575 shares of Bruker BioSciences Corporation common stock with the same vesting schedule at a purchase price of $11.11 per share. In connection with the Merger, filer's option to receive 2,500 shares of Bruker AXS Inc. common stock was converted into an option to receive 1,575 shares of Bruker BioSciences Corporation common stock with the same vesting schedule at a purchase price of $3.65 per share. Taylor J. Crouch 2003-07-02 -----END PRIVACY-ENHANCED MESSAGE-----